Latest filing published 16 Aug 2024 for 대원제약.
피델리티매니지먼트앤리서치컴퍼니엘엘씨: trading record in brief
This profile gathers the share dealings of 피델리티매니지먼트앤리서치컴퍼니엘엘씨 in 대원제약. Between 31 August 2021 and 13 August 2024, the trades on record add up to 4 filings.
Purchases make up the whole of the open-market record (4 purchases). The amount is not disclosed for 4 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 1 purchase and no sales on the market.
None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 16 August 2024, the filings show an open-market purchase in 대원제약. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 피델리티매니지먼트앤리서치컴퍼니엘엘씨
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 113,090 sharesKRXDART:20240816000165Canonical exit: 14 Nov 2024 (T+90)
- 113,090 sharesKRXDART:20231221000522Canonical exit: 20 Mar 2024 (T+90)
- 113,090 sharesKRXDART:20230704000487Canonical exit: 2 Oct 2023 (T+90)
- 113,090 sharesKRXDART:20210831001715Canonical exit: 29 Nov 2021 (T+90)
4 of 4 declarations